泽璟制药：2025年第一季度净亏损2826.22万元

Core Viewpoint - ZaiJing Pharmaceutical reported a revenue of 168 million yuan for the first quarter of 2025, representing a year-on-year growth of 54.87% [1] - The company incurred a net loss of 28.26 million yuan, an improvement from a net loss of 39.49 million yuan in the same period last year [1] Financial Performance - Revenue for Q1 2025: 168 million yuan, up 54.87% year-on-year [1] - Net loss for Q1 2025: 28.26 million yuan, compared to a net loss of 39.49 million yuan in Q1 2024 [1]